Clinical Trial Update: Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

View source ↗

Summary

A completed clinical trial investigating the use of Xofigo (radium-223 dichloride) in metastatic castration-resistant prostate cancer with bone metastases, spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Xofigo (radium-223 dichloride)

Snippet

Sponsor: Bayer | Conditions: Prostatic Neoplasms, Castration-Resistant | Status: COMPLETED